Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KARS1 | Q15046 | 8/20 | 0.53 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.45 |
| ▸ | CDK8 | P49336 | 1/20 | 0.45 |
| ▸ | IDH2 | P48735 | 1/20 | 0.45 |
| ▸ | SYK | P43405 | 7/20 | 0.45 |
| ▸ | KMO | O15229 | 1/20 | 0.44 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL902605 | 0.90 | KARS1 (0.56) | KARS1SYK | |
| SCHEMBL901986 | 0.90 | SYK (0.50) | KARS1IDH2SYK | |
| SCHEMBL12469132 | 0.86 | KARS1 (0.72) | KARS1SYKKMONR3C2 | |
| SCHEMBL901724 | 0.85 | KARS1 (0.57) | KARS1IDH2SYKKMO | |
| SCHEMBL902073 | 0.84 | KARS1 (0.71) | KARS1IDH2SYKNR3C2 | |
| SCHEMBL902028 | 0.84 | CA12 (0.45) | GPR52CDK8IDH2SYKNR3C2 | |
| SCHEMBL901883 | 0.83 | AURKA (0.56) | KARS1IDH2SYKKMONR3C2 | |
| SCHEMBL901864 | 0.83 | KARS1 (0.49) | KARS1IDH2SYKKMONR3C2 | |
| SCHEMBL901872 | 0.82 | KARS1 (0.52) | KARS1 | |
| SCHEMBL901844 | 0.80 | KARS1 (0.52) | KARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2441755-A1 | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors | Almirall, S.A. (ES) | 2012-04-18 | — | — | EP | disclosed |
| WO-2012041476-A1 | PYRIDINE AND ISOQUINOLINE DERIVATIVES AS SYK- AND JAK-KINASE INHIBITORS | ALMIRALL, S.A. (ES) | 2012-04-05 | — | — | WO | disclosed |